newsfilter
← Latest News
GlobeNewswire·

Vyant Bio to Present at the Q4 Investor Summit Micro & Small Cap Conference

Cherry Hill, N.J., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. ("Vyant Bio", "Company") (NASDAQ:VYNT), an emerging global drug discovery company, is rapidly identifying small and large molecule therapeutics to treat central nervous system (CNS)